8-K: Kewaunee Scientific Reports Robust Fiscal Year 2025 Results Driven by Strategic Acquisition and Strong Domestic Performance

Kewaunee Scientific Corporation announced strong financial results for its fiscal year and fourth quarter ended April 30, 2025, highlighted by significant sales growth and improved adjusted profitability, bolstered by the strategic acquisition of Nu Aire, Inc.

Summary

• Sales for the fourth quarter of fiscal year 2025 were $77,148,000, an increase of 36.1% compared to $56,702,000 in the prior year's fourth quarter.
• Pre-tax earnings for Q4 FY2025 were $7,149,000, significantly up from $1,347,000 in the prior year quarter.
• Net earnings for Q4 FY2025 were $4,850,000, compared to $11,026,000 in the prior year quarter, which included non-recurring tax benefits and pension adjustments.
• Diluted earnings per share for Q4 FY2025 were $1.63, compared to $3.71 in the prior year quarter.
• Adjusted pre-tax earnings for Q4 FY2025 were $8,407,000, a 56.7% increase from the prior year's adjusted $5,366,000, after accounting for Nu Aire acquisition and integration costs.
• Adjusted diluted earnings per share for Q4 FY2025 was $1.95, compared to adjusted $1.55 in the prior year quarter.
• Sales for the full fiscal year 2025 were $240,472,000, an 18.0% increase from $203,755,000 in the prior year.
• Pre-tax earnings for FY2025 were $14,785,000, up from $13,119,000 in the prior year.
• Net earnings for FY2025 were $11,405,000, compared to $18,753,000 in the prior year, impacted by prior year non-recurring transactions.
• Diluted earnings per share for FY2025 was $3.83, compared to $6.38 in the prior fiscal year.
• Adjusted pre-tax earnings for FY2025 were $20,827,000, a 21.5% increase from the prior year's adjusted $17,138,000.
• Adjusted diluted earnings per share for FY2025 was $5.37, compared to adjusted $4.19 in the prior year.
• The company's order backlog was $214.6 million on April 30, 2025, a slight decrease from $221.6 million on January 31, 2025, but an increase from $155.6 million on April 30, 2024.
• The acquisition of Nu Aire, Inc. on November 1, 2024, incurred $1,258,000 in Q4 FY2025 and $6,042,000 for FY2025 in pre-tax earnings reduction due to acquisition, integration, and purchase accounting costs.

Sentiment

Score: 8

Explanation: The company reported strong sales growth and significantly improved adjusted profitability for both the fourth quarter and the full fiscal year 2025. The strategic acquisition of Nu Aire is a key growth driver, and the company maintains a healthy backlog. While GAAP net earnings were lower due to non-recurring items in the prior year and increased debt from the acquisition, the underlying operational performance and strategic positioning are robust.

Positives

• Achieved strong sales growth of 36.1% in Q4 FY2025 and 18.0% for the full fiscal year 2025.
• Reported significant increases in adjusted pre-tax earnings (56.7% in Q4, 21.5% in FY2025) and adjusted diluted EPS, indicating robust operational performance.
• EBITDA and Adjusted EBITDA saw substantial increases for both the quarter and the full fiscal year.
• Successfully completed the strategic acquisition of Nu Aire, Inc., which is expected to drive future growth and expand the product portfolio.
• Maintained a robust and healthy order backlog of $214.6 million at fiscal year-end, indicating strong future revenue potential.
• Domestic segment sales and profitability improved significantly due to higher manufacturing volumes and the incorporation of Nu Aire's results.
• The impact of customer site delays in the International segment decreased in Q4, leading to increased deliveries and billings.
• Working capital increased to $64,651,000 on April 30, 2025, from $56,037,000 on April 30, 2024, reflecting improved financial health.
• Management emphasizes continued investments in product portfolio, manufacturing assets, and strengthening dealer and distribution relationships.

Negatives

• GAAP net earnings and diluted EPS decreased significantly in Q4 and FY2025 compared to the prior year, primarily due to non-recurring tax benefits and pension adjustments recorded in the prior fiscal year.
• International segment sales decreased by 8.2% for the full fiscal year due to customer site delays that pushed out timing of deliveries and billings.
• International segment profitability decreased year-over-year.
• Corporate segment reported a net loss for both the quarter and fiscal year, impacted by professional service and other fees related to the Nu Aire acquisition and Sarbanes-Oxley 404(b) compliance readiness costs.
• Cash on hand decreased to $17,164,000 on April 30, 2025, from $25,938,000 on April 30, 2024, primarily due to the Nu Aire acquisition.
• Total debt increased substantially, with short-term debt rising to $4,773,000 and long-term debt to $60,730,000 on April 30, 2025, compared to the prior year.
• The debt-to-equity ratio increased to 0.99-to-1 on April 30, 2025, from 0.70-to-1 on April 30, 2024.

Risks

• Ability to realize the anticipated benefits as a result of the Nu Aire acquisition.
• Competitive and general economic conditions, including disruptions from government mandates, both domestically and internationally.
• Supplier constraints and other supply disruptions.
• Changes in customer demands.
• Technological changes in operations or in the industry.
• Dependence on customers' required delivery schedules.
• Fluctuations in operating results from quarter to quarter.
• Risks related to international operations, including foreign currency fluctuations.
• Changes in the legal and regulatory environment.
• Changes in raw materials and commodity costs.
• Acts of terrorism, war, governmental action, and natural disasters and other Force Majeure events.

Future Outlook

The company expects to continue to grow both organically and inorganically, leveraging its culture to adapt, grow, and deliver lasting value for its customers, communities, partners, and shareholders. It also positions itself as a trusted partner for business owners seeking stewardship and continuity for their company's future.

Management Comments

• "Kewaunee again delivered another strong quarter, closing out fiscal year 2025 on a high note. Our team continues to embrace the momentum we have generated in the market, delivering on our commitments to our customers, which continues to result in Kewaunee being the preferred supplier of choice for customers looking to furnish laboratory spaces." Thomas D. Hull, III, President and Chief Executive Officer.
• "Our strategy to emphasize investments in our product portfolio and manufacturing assets while strengthening our dealer and distribution relationships continues to drive performance improvement." Thomas D. Hull, III, President and Chief Executive Officer.
• "Fiscal year 2025 was marked by exceptional performance from our Kewaunee team. The Company delivered excellent financial results and closed the year with a robust and healthy backlog. These results reflect the consistent execution and dedication of our global team." Thomas D. Hull III, President and Chief Executive Officer.
• "While our industry has been facing a period of instability driven by geopolitical uncertainty, unclear tariff policies and ongoing supply chain disruptions, Kewaunee has responded with resilience. Kewaunee's culture is one of preparedness and a bias towards action which has enabled us to thrive in the midst of these uncertainties." Thomas D. Hull III, President and Chief Executive Officer.
• "In November of this past year, Kewaunee took a significant step forward in our growth journey with the acquisition of Nu Aire, Inc., a pioneer in laboratory equipment and biosafety solutions. This move was guided by a clear strategic intent: To bring together two market leaders with complementary strengths, shared values, and a common vision for the future of laboratory innovation." Thomas D. Hull III, President and Chief Executive Officer.

Industry Context

The announcement highlights Kewaunee Scientific's strong performance despite broader industry instability driven by geopolitical uncertainty, unclear tariff policies, and ongoing supply chain disruptions. The company's culture of preparedness and bias towards action has enabled it to thrive amidst these challenges. The acquisition of Nu Aire, Inc. is a significant strategic move aimed at consolidating market leadership and enhancing the company's portfolio in laboratory innovation, aligning with a trend of strategic consolidation and diversification within specialized equipment sectors.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for increased value through strategic growth and improved operational performance, though accompanied by increased debt levels.
• Employees: Acknowledged for their consistent execution and dedication, contributing to a high-performing culture.
• Customers: Benefiting from Kewaunee being a preferred supplier, delivering on commitments, and providing solutions for critical laboratory needs.
• Channel Partners: Recognized for their valuable support and collaborative efforts in bringing solutions to customers and winning projects.
• Communities: Commitment to delivering lasting value to communities.

Next Steps

• Continue to grow both organically and inorganically.
• Leverage company culture to adapt, grow, and deliver lasting value for customers, communities, partners, and shareholders.
• Offer stewardship, continuity, and partnership for business owners looking for the next chapter.

Key Dates

Recommendation

Keywords

laboratory equipment, biosafety solutions, lab furniture, fume hoods, Kewaunee Scientific, Nu Aire, financial results, earnings report, acquisition, EBITDA, backlog, corporate governance, risk management